![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() by AFP Staff Writers Cape Town (AFP) June 2, 2021
South African President Cyril Ramaphosa on Wednesday welcomed the World Health Organisation's approval of Sinovac Covid-19 vaccine for emergency use, hoping it will mean more vaccines for his population and those in poorer countries. The emergency approval for the Beijing-based firm Sinovac's two-dose vaccine CoronaVac, announced Tuesday, opens the door for the jabs to be included in the Covax global vaccine-sharing facility, which aims to provide equitable access to doses around the world, particularly in poorer countries. "We welcome the news that the World Health Organisation has validated the Sinovac from China covid-19 vaccine for emergency use," Ramaphosa told parliament in Cape Town. Ramaphosa lauded the go-ahead as "a crucial step" that should move South Africa's regulatory authorities to look into purchasing Sinovac. The Sinovac serum is "easy to store" and therefore "easy to manage, and particularly suitable for countries with few resources", said WHO. With over 1.6 million cases of which 56,601 were fatalities, around 1,045,104 people in South Africa have so far received jabs, mainly the elderly --who are yet to receive a second jab -- and healthcare workers, using the Pfizer and Johnson & Johnson vaccines. Ramaphosa said the government, which has been widely criticised for a slow vaccination drive, is continuing to engage with various manufacturers to ensure a reliable and diverse supply of vaccines. But he stressed, once again, the need to waive intellectual property rights over coronavirus jabs, arguing it would speed up vaccine distribution and boost the local pharmaceutical market. "It will pave the way for the development and growth of local pharmaceutical industries in our own country, on the continent as well and in other developing countries." The global campaign championed by South Africa and India to temporarily waive intellectual property rights for Covid vaccines was supported by the other BRICS countries -- Brazil, Russia, China -- at this week's meeting of five of the world's biggest emerging economies held in Delhi. mgu/har
![]() ![]() China confirms first human case of bird flu strain Beijing (AFP) June 1, 2021 China reported the world's first human infection of the H10N3 bird flu strain on Tuesday but said the risk of it spreading widely among people was low. A 41-year-old man was admitted to hospital with fever symptoms in the eastern city of Zhenjiang on April 28 and was diagnosed with H10N3 a month later, China's National Health Commission (NHC) said in an online statement. "The risk of large-scale spread is extremely low," the NHC said, adding that the man was in a stable condition and his close c ... read more
![]() |
|
The content herein, unless otherwise known to be public domain, are Copyright 1995-2024 - Space Media Network. All websites are published in Australia and are solely subject to Australian law and governed by Fair Use principals for news reporting and research purposes. AFP, UPI and IANS news wire stories are copyright Agence France-Presse, United Press International and Indo-Asia News Service. ESA news reports are copyright European Space Agency. All NASA sourced material is public domain. Additional copyrights may apply in whole or part to other bona fide parties. All articles labeled "by Staff Writers" include reports supplied to Space Media Network by industry news wires, PR agencies, corporate press officers and the like. Such articles are individually curated and edited by Space Media Network staff on the basis of the report's information value to our industry and professional readership. Advertising does not imply endorsement, agreement or approval of any opinions, statements or information provided by Space Media Network on any Web page published or hosted by Space Media Network. General Data Protection Regulation (GDPR) Statement Our advertisers use various cookies and the like to deliver the best ad banner available at one time. All network advertising suppliers have GDPR policies (Legitimate Interest) that conform with EU regulations for data collection. By using our websites you consent to cookie based advertising. If you do not agree with this then you must stop using the websites from May 25, 2018. Privacy Statement. Additional information can be found here at About Us. |